Autologous PBMNC cell therapy in the treatment of critical ischemia and the diabetic foot
Autologus Peripheral Blood Mononuclear Cells in Patients with Small Artery Disease and Diabetic Foot Ulcers: Efficacy, Safety, And Eco-Nomic Evaluation
Benedetta Ragghianti , Bianca Maria Berardi , Edoardo Mannucci and Matteo Monami ,
Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no‑option critical limb‑threatening ischemia and severe diabetic foot ulcers
Andrea Panunzi, Fabiana Madotto, Elena Sangalli, Federica Riccio, Adriana Barbara Sganzaroli, Paolo Galenda, Amelia Bertulessi, Maria Francesca Barmina, Ornella Ludovico, Orazio Fortunato, Francesco Setacci, Flavio Airoldi, Davide Tavano, Laura Giurato, Marco Meloni, Luigi Uccioli, Antonino Bruno, Gaia Spinetti and Carlo Maria Ferdinando Caravaggi
Treatment with PBMNC in Critical Limb Ischaemia and Biomarker Candidates
Zamboni,M ;Pedriali, M; Ferretto,L; Scian, S; Ghirardini, F; Bozza, R; Martini, R; Irsara,S;
Peripheral blood mononuclear cell therapy for the treatment of lower limb ischaemia in diabetic patients
Persiani, F; Paolini, A; Camilli, D; Mascellari, L; Platone, A; Magenta, A; Furgiuele, S.…
Autologus Peripheral Blood Mononuclear Cells for Limb Salvage in Diabetic foot Patients with No-Option Critical Limb Ischemia
Scatena, A.; Petruzzi, P.; Maioli, F.; Lucaroni, F.; Ambrosone, C.; Ventoruzzo, G.; Liistro, F.; Tacconi, D.; Filippi, M. Di; Attempati, N.; et al.
Autologus cell therapy in diabetes-associated critical limb ischemia: From basic studies to clinical outcomes
Magenta, A.; Florio, M.C.; Ruggeri, M.; Furgiuele, S.